Juan C. Gea-Banacloche, M.D.
Juan C. Gea-Banacloche, M.D.
Staff Clinician

Center for Cancer Research
National Cancer Institute

Building 10 - Hatfield CRC, Room 3-3130
Bethesda, MD 20892-1203
301-435-2326

Dr. Gea-Banacloche received his medical education at the Universidad Autonoma Medical School in Madrid, Spain. After completing his internal medicine training in Madrid and working in the Department of Internal Medicine at the University Hospital Clinica Puerta de Hierro in Madrid, Spain, he moved to the NIH where he obtained allergy and immunology and infectious diseases training under Dr. H. Clifford Lane of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID). His research during this time involved immune reconstitution in HIV disease and antiviral-specific T-cell responses. In 2000 he joined the Experimental Transplantation and Immunology Branch of NCI as an infectious diseases consultant. Since then, he has focused on clinical infectious diseases in immunocompromised patients. Most recently, he has collaborated in developing the Sepsis Survival Campaign Guidelines (2004). Since early 2005, he has been chief of the NIH Infectious Disease Consultation Service, a joint collaboration between NCI and the Laboratory of Clinical Infectious Diseases, NIAID.

Areas of Expertise
immuniocompromise, infectious desease
Selected Publications
  1. Kochenderfer JN, Dudley ME, Carpenter RO, Kassim SH, Rose JJ, Telford WG, Hakim FT, Halverson DC, Fowler DH, Hardy NM, Mato AR, Hickstein DD, Gea-Banacloche JC, Pavletic SZ, Sportes C, Maric I, Feldman SA, Hansen BG, Wilder JS, Blacklock-Schuver B, Jena B, Bishop MR, Gress RE, Rosenberg SA.
    Blood. 122: 4129-39, 2013. [ Journal Article ]
  2. Gea-Banacloche J.
    Hematology Am Soc Hematol Educ Program. 2013: 414-22, 2013. [ Journal Article ]
  3. Markus J, Garin MT, Bies J, Galili N, Raza A, Thirman MJ, Le Beau MM, Rowley JD, Liu PP, Wolff L.
    Cancer Res.. 67: 992-1000, 2007. [ Journal Article ]
  4. Slape C, Hartung H, Lin YW, Bies J, Wolff L, Aplan PD.
    Cancer Res.. 67: 5148-55, 2007. [ Journal Article ]
  5. Sramko M, Markus J, Kabát J, Wolff L, Bies J.
    J. Biol. Chem.. 281: 40065-75, 2006. [ Journal Article ]

Dr. Gea-Banacloche received his medical education at the Universidad Autonoma Medical School in Madrid, Spain. After completing his internal medicine training in Madrid and working in the Department of Internal Medicine at the University Hospital Clinica Puerta de Hierro in Madrid, Spain, he moved to the NIH where he obtained allergy and immunology and infectious diseases training under Dr. H. Clifford Lane of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID). His research during this time involved immune reconstitution in HIV disease and antiviral-specific T-cell responses. In 2000 he joined the Experimental Transplantation and Immunology Branch of NCI as an infectious diseases consultant. Since then, he has focused on clinical infectious diseases in immunocompromised patients. Most recently, he has collaborated in developing the Sepsis Survival Campaign Guidelines (2004). Since early 2005, he has been chief of the NIH Infectious Disease Consultation Service, a joint collaboration between NCI and the Laboratory of Clinical Infectious Diseases, NIAID.

Name Position
Maria Vivancos-Gallego Special Volunteer

Summary

Dr. Gea-Banacloche received his medical education at the Universidad Autonoma Medical School in Madrid, Spain. After completing his internal medicine training in Madrid and working in the Department of Internal Medicine at the University Hospital Clinica Puerta de Hierro in Madrid, Spain, he moved to the NIH where he obtained allergy and immunology and infectious diseases training under Dr. H. Clifford Lane of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID). His research during this time involved immune reconstitution in HIV disease and antiviral-specific T-cell responses. In 2000 he joined the Experimental Transplantation and Immunology Branch of NCI as an infectious diseases consultant. Since then, he has focused on clinical infectious diseases in immunocompromised patients. Most recently, he has collaborated in developing the Sepsis Survival Campaign Guidelines (2004). Since early 2005, he has been chief of the NIH Infectious Disease Consultation Service, a joint collaboration between NCI and the Laboratory of Clinical Infectious Diseases, NIAID.

Areas of Expertise
immuniocompromise, infectious desease

Publications

Selected Publications
  1. Kochenderfer JN, Dudley ME, Carpenter RO, Kassim SH, Rose JJ, Telford WG, Hakim FT, Halverson DC, Fowler DH, Hardy NM, Mato AR, Hickstein DD, Gea-Banacloche JC, Pavletic SZ, Sportes C, Maric I, Feldman SA, Hansen BG, Wilder JS, Blacklock-Schuver B, Jena B, Bishop MR, Gress RE, Rosenberg SA.
    Blood. 122: 4129-39, 2013. [ Journal Article ]
  2. Gea-Banacloche J.
    Hematology Am Soc Hematol Educ Program. 2013: 414-22, 2013. [ Journal Article ]
  3. Markus J, Garin MT, Bies J, Galili N, Raza A, Thirman MJ, Le Beau MM, Rowley JD, Liu PP, Wolff L.
    Cancer Res.. 67: 992-1000, 2007. [ Journal Article ]
  4. Slape C, Hartung H, Lin YW, Bies J, Wolff L, Aplan PD.
    Cancer Res.. 67: 5148-55, 2007. [ Journal Article ]
  5. Sramko M, Markus J, Kabát J, Wolff L, Bies J.
    J. Biol. Chem.. 281: 40065-75, 2006. [ Journal Article ]

Biography

Dr. Gea-Banacloche received his medical education at the Universidad Autonoma Medical School in Madrid, Spain. After completing his internal medicine training in Madrid and working in the Department of Internal Medicine at the University Hospital Clinica Puerta de Hierro in Madrid, Spain, he moved to the NIH where he obtained allergy and immunology and infectious diseases training under Dr. H. Clifford Lane of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID). His research during this time involved immune reconstitution in HIV disease and antiviral-specific T-cell responses. In 2000 he joined the Experimental Transplantation and Immunology Branch of NCI as an infectious diseases consultant. Since then, he has focused on clinical infectious diseases in immunocompromised patients. Most recently, he has collaborated in developing the Sepsis Survival Campaign Guidelines (2004). Since early 2005, he has been chief of the NIH Infectious Disease Consultation Service, a joint collaboration between NCI and the Laboratory of Clinical Infectious Diseases, NIAID.

Team

Name Position
Maria Vivancos-Gallego Special Volunteer